Table 8. Comparison of surgical technique and hormone therapy status and the mean score of EORTC QLQ-C30 cancer quality of life scale in the study.

Variables	Weakness			P*	Nausea			P*	Ache			P*
	First day x±SD	Last day x ± SD	Three months later X ± SD		First day X ± SD	Last day x±SD	Three months later x±SD		First day x±SD	Last day X ± SD	Three months later X ± SD
Surgery
MRM (n=37)	36.34 ± 19.54	42.64 ± 18.43	40.54 ± 19.28	0.351	22.97 ± 26.16	26.13 ± 26.51	21.62 ± 25.11	0.769	20.27 ± 20.84	1 9.37 ± 19.84	18.47 ± 18.75	0.935
BCS (n= 72)	45.22 ± 31.56	43.36 ±18.85	40.59 ± 18.19	0.529	22.92 ± 24.77	19.91 ± 23.01	24.31 ± 28.10	0.592	20.83 ± 22.16	18.52 ±21.95	21.76 ± 23.51	0.666
p#	0.121	0.849	0.990		0.991	0.207	0.626		0.898	0.844	0.462
Hormone therapy
No (n= 16)	50.69 ± 52.58	49.31 ±20.27	40.97 ±22.12	0.742	30.21 ± 28.03	18.75 ± 21.84	28.13 ± 32.04	0.431	23.96 ± 29.79	20.83 ± 30.12	30.21 ± 19.45	0.662
Yes (n= 93)	40.74 ± 21.75	42.06 ± 18.23	40.50 ± 17.92	0.841	21.68 ± 24.55	22.58 ± 24.78	22.58 ± 26.20	0.966	20.07 ± 20.05	18.46 ± 19.42	1 9.00 ± 22.06	0.858
p#	0.195	0.151	0.926		0.212	0.563	0.451		0.509	0.681	0.059
According to the multiple comparison test result (Bonferroni), the difference in alphabetical exponents indicates statistically significant. p*: Repeated measure analysis of variance, p#: Student's t test, x: Arithmetic mean, SD: Standard deviation, BCS: Breast conserving surgery, MRM: Modified radical mastectomy.